Freshfields advised Roivant on Sale of Telavant to Roche. Switzerland’s Roche (ROG.S) has entered into an agreement to pay an initial $7.1 billion to Roivant (ROIV.O)...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here